CN106755135A - It is a kind of to synthesize caffeinic method by substrate resting cell of levodopa - Google Patents
It is a kind of to synthesize caffeinic method by substrate resting cell of levodopa Download PDFInfo
- Publication number
- CN106755135A CN106755135A CN201611158372.2A CN201611158372A CN106755135A CN 106755135 A CN106755135 A CN 106755135A CN 201611158372 A CN201611158372 A CN 201611158372A CN 106755135 A CN106755135 A CN 106755135A
- Authority
- CN
- China
- Prior art keywords
- caffeinic
- leu
- ala
- ser
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/03—Oxo-acid-lyases (4.1.3)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Synthesize caffeinic method by substrate resting cell of levodopa the invention discloses one kind, belong to biological chemical field.The present invention with levodopa be substrate biosynthesis caffeic acid.Compared with the conventional method for transformation with L tyrosine as substrate, the method substrate solubility is higher, and yield is high, conversion ratio, and production efficiency is high.Compared with chemical synthesis process, the product of the method is single anti-caffeic acid, it is not necessary to which isomer is further separated.Up to 910.90mg/L, conversion ratio is 99.70% to caffeinic yield after reacting 6 hours.
Description
Technical field
Synthesize caffeinic method by substrate resting cell of levodopa the present invention relates to one kind, belong to biochemical industry
Field.
Background technology
Caffeic acid is a kind of aromatic compounds of high value, and hydroxycinnamic acid can be divided into structure, and it has simultaneously
2 functional groups of phenolic hydroxyl group and acrylic acid.Research in vivo and in vitro shows that caffeic acid has a series of physiological functions.For example, passing through
Oxidation mechanism, caffeic acid can suppress cancer cell multiplication;Caffeic acid has immunological regulation and anti-inflammatory activity;Caffeic acid can act also as
Antioxidant, and better than other native compounds;In addition, caffeic acid also has antiviral, antidepression, treatment diabetes etc. living
Property.
Used as the crucial mesostate of lignin synthesis, caffeic acid is present in nearly all plant.The approach with
TYR or L-phenylalanine are precursor, are related to trans-Cinnamate 4-monooxygenase (CYP73A), phenylalanine/tyrosine
Amino lyase, p-Coumaric Acid 3- hydroxylases etc..However, content of the caffeic acid in plant is universal very low, therefore extract difficult.
On the other hand, the caffeic acid being chemically synthesized is take advantage of a situation caffeic acid and trans caffeinic mixture;And due to the phase of structure
Like property, it is kept completely separate that to be purified into single any compound all more difficult.
By synthetic biology approach strategy, the route of synthesis by caffeic acid in plant is moved in microorganism chassis,
It is Research Thinking main at present to build the engineering bacteria with caffeic acid synthesis capability.However, molten due to substrates such as tyrosine
Solution property is poor, the coffee acid yield of such engineering bacteria and relatively low to the conversion ratio of substrate.By with TYR superior strain
As the chassis of the heterologous route of synthesis of caffeic acid, help to solve the problem, but effect is unsatisfactory, it shows as production week
Phase is more long, and yield is not significantly improved.
The content of the invention
The problem to be solved in the present invention is to provide a kind of caffeinic biological synthesis method, therefore, present invention firstly provides
A kind of recombination bacillus coli for expressing tyrosine amino lyase.
Described tyrosine amino lyase RgTAL derives from rhodotorula glutinis (Rhodotorula glutinis), its ammonia
As shown in SEQ ID NO.1, the gene order of encoding tyrosine amino lyase is as shown in SEQ ID NO.2 for base acid sequence.
Described Escherichia coli are e. coli bl21 (DE3).
Expression vector used is pET-28a (PB), and as shown in SEQ ID NO.3, gene RgTAL passes through its DNA sequence dna
Restriction enzyme site Bam HI/Hind III are subcloned to expression vector pET-28a (PB).
The present invention is also provided and produces caffeinic method with the recombination bacillus coli, is, with levodopa as substrate, to lead to
Cross restructuring E. coli whole cell Synthesis caffeic acid.
In described transformation system, the reaction medium of resting cell is the phosphate buffer of 10-200mM, full cell
The concentration of recombination bacillus coli is OD in transformation system600=20 ± 1, substrate concentration range is 0.01-10g/L, described reaction
The pH scopes of system are 6.0-9.0, and range of reaction temperature is 25-42 DEG C.
In one embodiment of the invention, described reaction medium is the phosphate buffer of 10-200mM.
In one embodiment of the invention, the reaction medium of resting cell is the phosphate buffer of 50mM, entirely
The concentration of recombination bacillus coli is OD in cell transformation system600=20 ± 1, concentration of substrate is 1g/L, described reaction system
PH scopes are 7.5, and range of reaction temperature is 37 DEG C.
In one embodiment of the invention, the culture of recombination bacillus coli uses TB culture mediums.
Usefulness of the present invention:Invention creates a kind of caffeinic biosynthesis side with levodopa as substrate
Method.Compared with the conventional method for transformation with TYR as substrate, the method substrate solubility is higher, and yield is high, conversion ratio,
And production efficiency is high.Compared with chemical synthesis process, the product of the method is single trans- caffeic acid, it is not necessary to different with dividing
Structure body is further separated.Under this preferably reaction condition, caffeinic yield is 910.90mg/L after reacting 6 hours,
Conversion ratio is 99.70%.Synthesize caffeinic method to be currently known a kind of bioanalysis of conversion ratio highest.
Brief description of the drawings
The caffeinic chromatograms of Fig. 1.Wherein, 1 is the corresponding chromatographic peak of caffeic acid.
Caffeinic mass spectrogram under Fig. 2 ion modes.Wherein, A is the corresponding extraction particle fluxes of 179.0350m/z;B is
Caffeinic first mass spectrometric figure;C is the corresponding second order mses figure of caffeic acid.
The corresponding coffee acid yield of different time points in Fig. 3 conversion processes.
Caffeinic yield under Fig. 4 condition of different temperatures.
Caffeinic yield under Fig. 5 condition of different pH.
Caffeinic yield and conversion ratio under the conditions of Fig. 6 difference concentration of substrate.
Specific embodiment
Materials and methods
Caffeic acid and levodopa (L-DOPA) standard items are purchased from Sigma-Aldrich (St.Louis, MO),
Rhodotorula glutinis tyrosine amino lyase genes RgTAL is optimized and is closed by Jin Sirui bio tech ltd
Into sequence is SQ2.
The configuration of TB culture mediums:Dusty yeast 24g/L, tryptone 12g/L, glycerine 4ml/L, potassium dihydrogen phosphate 17mM, phosphorus
Sour hydrogen dipotassium 72mM.To prevent precipitation, potassium dihydrogen phosphate/dipotassium hydrogen phosphate is configured to 10 times of mother liquors of concentration, filtration sterilization,
Use preceding addition.121 DEG C of high pressure steam sterilization 15min of other compositions.
The configuration of 50mM phosphate buffers PBS:It is respectively configured the NaH of 50mM2PO4With the Na of 50mM2HPO4, with
NaH2PO4Titration Na2HPO4To different pH.
Sample analysis:By sample 12000rpm be centrifuged 2min, take supernatant, with 10 times of methanol dilution after, use 0.22 μm filter
Membrane filtration.Sample analysis uses Shimadzu LC-MS/MS-IT-TOF, the μ L of sampling volume 10, uses automatic sampler sample introduction.
Use C18 reverse chromatograms post (Thermo scientific, ODS-2HYPERSIL, Dim. (mm) 250 × 4.6, particle
Size5 μm) sample is separated.Mobile phase A is water, and Mobile phase B is methyl alcohol.Using gradient elution, 0min 5%B,
8min25%B, 9min 5%B, maintain the concentration to 12min.Flow velocity is 1mL/min.Column temperature:40℃.Using UV-detector,
λ=323nm determines caffeic acid, and λ=280nm determines levodopa.Mass spectral analysis uses negative ion mode, to extract ion stream
(extracted ion chromatograms, EIC) m/z=179.0350 detects caffeic acid, to extract ion stream m/z=
196.0615 detection levodopas.The precursor of second order mses MS/MS analyses is respectively:Caffeic acid 179.0350m/z, levodopa
196.0615m/z;Width is set to 1Da.Compared by the retention time with standard items, first mass spectrometric, second order mses figure,
Determine target substance.Quantitative analysis is carried out to caffeic acid and levodopa using the peak area of liquid chromatogram.
Embodiment 1
The construction method of recombination bacillus coli:RgTAL is cloned into by Jin Sirui bio tech ltd optimum synthesis
PUC57-Simple, recombinant plasmid is named as pUC57-TcXAL.Weight is digested using restriction enzyme Bam HI/Hind III
Group carrier pUC57-TcXAL and expression vector pET-28a (+), are separated using agarose gel electrophoresis and do not cut product, and returned respectively
Receive genes of interest RgTAL (2082bp) and expression vector (5368bp).According to mol ratio 4:Genes of interest after 1 Double digestion and
Expression vector, is connected overnight using T4 ligases under the conditions of 16 DEG C.Connection product conversion e. coli jm109 competence is thin
Born of the same parents, are coated with the LB flat boards containing 50 μ g/mL kanamycins.Positive transformant is verified by bacterium colony PCR, the primer sequence is
SQ4/SQ5.Positive transformant is forwarded to the LB liquid medium containing 50 μ g/mL kanamycins, 37 DEG C, 220rpm overnight trains
Plasmid is extracted after supporting, plasmid is converted into e. coli bl21 (DE3) competent cell, that is, obtain expressing the restructuring large intestine of RgTAL
Bacillus engineered strain, is named as E.coli DCA-2.
The cultural method of recombination bacillus coli:The single bacterium colony that plate streaking is separate is forwarded to containing 50 μ g/mL cards that is mould
The LB liquid medium of element, 37 DEG C, 220rpm incubated overnights.It is forwarded to the inoculum concentration of 1% (v/v) and is cultivated equipped with 25mL TB
In the 250mL triangular flasks of base, while the kanamycins of the final concentration of 50 μ g/mL of addition.37 DEG C, 220rpm culture 4h after, addition
Final concentration of 500 μM of IPTG induces the expression of RgTAL, and triangular flask is transferred into 25 DEG C, 220rpm, continues to cultivate 10h.By bacterium
Liquid is collected into centrifuge tube, 4000rpm, 4 DEG C of centrifugation 5min collects thallines.
Caffeinic resting cell method:With the thalline that 25mL PBS washings are collected, it is resuspended in after centrifugation isometric
In PBS (50mM, pH 7.0), cell concentration is OD600=18 ± 1.The levodopa of final concentration of 1g/L is added the bottom of as simultaneously
Thing is reacted, and the reaction is carried out on 37 DEG C, 220rpm constant-temperature tables.With the large intestine bar containing empty plasmid pET-28a (PB)
Bacterium BL21 (DE3) is used as blank.Particular point in time is sampled, and determines caffeinic synthesis situation.
Result shows, to have caffeinic synthesis in the reaction system that E.coli DCA-2 are catalyzed, and in blank then
It is not detected by caffeic acid.Result verification RgTAL catalyzing levorotatories DOPA synthesizes caffeinic ability, and the building-up process can not
It is spontaneous to carry out.Caffeinic chromatogram such as Fig. 1, wherein, 1 is the corresponding peak of caffeic acid;Caffeinic mass spectrogram as shown in Fig. 2
To extract particle flux, B is first mass spectrometric figure to wherein A, and C is second order mses figure.Sampling time point is made by caffeinic yield
Figure, it may be determined that reach maximum production 626.10mg/L 8 hours caffeic acids are converted, conversion ratio is 68.53%, as shown in Figure 3.
The temperature of embodiment 2 is on the caffeinic influence of Synthesis
Temperature conditionss in caffeic acid conversion process are optimized, using recombination bacillus coli E.coli DCA-2 as catalysis
Agent, with PBS (50mM, pH 7.0) as reaction medium, levodopa addition concentration is 1g/L.Respectively 20 DEG C, 25 DEG C, 30
DEG C, converted under the temperature conditionss of 37 DEG C and 42 DEG C, speed setting is 220rpm.Because caffeic acid reached maximum at 6 hours
Yield, therefore sampled at the 6th hour, determine caffeinic yield and conversion ratio.
As shown in figure 4, as a result showing, caffeinic yield increases with the rising of temperature, after temperature is more than 37 DEG C, coffee
The yield of coffee acid does not increase to be reduced on the contrary.This may be with caffeic acid under higher temperature conditions degraded it is relevant.Under the conditions of 37 DEG C
After conversion 6 hours, caffeic acid reaches maximum production, i.e. 865.75mg/L, and conversion ratio is 94.76%.
Embodiment 3pH produces the influence of result to caffeic acid
PH conditions in caffeic acid conversion process are optimized, using recombination bacillus coli E.coli DCA-2 as catalysis
Agent, levodopa addition concentration is 1g/L.Conversion condition is set as 37 DEG C, 220rpm.Respectively with different pH (6.0,6.5,7.0,
7.5th, 8.0, PBS (50mM) 8.5) is used as conversion medium.Sampled at the 6th hour respectively, determine caffeinic yield and conversion
Rate.
As shown in figure 5, as a result showing, caffeinic yield increases with the rising of pH, after pH is more than 7.5, coffee
The yield of acid starts to reduce.It is relevant that this may in the basic conditions be easily converted to benzoquinone compound with caffeic acid.At 37 DEG C
Under the conditions of conversion 6 hours after, caffeic acid reaches maximum production, i.e. 910.90mg/L, and conversion ratio is 99.70%, to be currently known
A kind of method of conversion ratio highest in bioanalysis synthesis caffeic acid.
The influence that the different concentration of substrate of embodiment 4 are produced to caffeic acid
Concentration of substrate in caffeic acid conversion process is optimized, using recombination bacillus coli E.coli DCA-2 as urging
Agent, levodopa addition concentration is respectively 2g/L, 5g/L and 10g/L.Conversion condition be above-mentioned optimal conditions, i.e., 37 DEG C,
220rpm、pH 7.5.Sampled at the 6th hour, determine caffeinic yield and conversion ratio.
As shown in fig. 6, as a result showing, with the increase of concentration of substrate, caffeinic yield is improved constantly, during 10g/L
Coffee acid yield highest, reaches 4.33g/L.But, with the raising of concentration of substrate, the conversion ratio of substrate is constantly reduced.Reason
May is that, substrate is not yet converted completely in 6h.Therefore, extension transformation time is advantageously possible for further improving turning for substrate
Rate.
Although the present invention is disclosed as above with preferred embodiment, it is not limited to the present invention, any to be familiar with this skill
The people of art, without departing from the spirit and scope of the present invention, can do various changes with modification, therefore protection model of the invention
Enclose being defined of being defined by claims.
SEQUENCE LISTING
<110>Southern Yangtze University
<120>It is a kind of to synthesize caffeinic method by substrate resting cell of levodopa
<160> 5
<170> PatentIn version 3.3
<210> 1
<211> 693
<212> PRT
<213> Rhodotorula glutinis
<400> 1
Met Ala Pro Arg Pro Thr Ser Gln Ser Gln Ala Arg Thr Cys Pro Thr
1 5 10 15
Thr Gln Val Thr Gln Val Asp Ile Val Glu Lys Met Leu Ala Ala Pro
20 25 30
Thr Asp Ser Thr Leu Glu Leu Asp Gly Tyr Ser Leu Asn Leu Gly Asp
35 40 45
Val Val Ser Ala Ala Arg Lys Gly Arg Pro Val Arg Val Lys Asp Ser
50 55 60
Asp Glu Ile Arg Ser Lys Ile Asp Lys Ser Val Glu Phe Leu Arg Ser
65 70 75 80
Gln Leu Ser Met Ser Val Tyr Gly Val Thr Thr Gly Phe Gly Gly Ser
85 90 95
Ala Asp Thr Arg Thr Glu Asp Ala Ile Ser Leu Gln Lys Ala Leu Leu
100 105 110
Glu His Gln Leu Cys Gly Val Leu Pro Ser Ser Phe Asp Ser Phe Arg
115 120 125
Leu Gly Arg Gly Leu Glu Asn Ser Leu Pro Leu Glu Val Val Arg Gly
130 135 140
Ala Met Thr Ile Arg Val Asn Ser Leu Thr Arg Gly His Ser Ala Val
145 150 155 160
Arg Leu Val Val Leu Glu Ala Leu Thr Asn Phe Leu Asn His Gly Ile
165 170 175
Thr Pro Ile Val Pro Leu Arg Gly Thr Ile Ser Ala Ser Gly Asp Leu
180 185 190
Ser Pro Leu Ser Tyr Ile Ala Ala Ala Ile Ser Gly His Pro Asp Ser
195 200 205
Lys Val His Val Val His Glu Gly Lys Glu Lys Ile Leu Tyr Ala Arg
210 215 220
Glu Ala Met Ala Leu Phe Asn Leu Glu Pro Val Val Leu Gly Pro Lys
225 230 235 240
Glu Gly Leu Gly Leu Val Asn Gly Thr Ala Val Ser Ala Ser Met Ala
245 250 255
Thr Leu Ala Leu His Asp Ala His Met Leu Ser Leu Leu Ser Gln Ser
260 265 270
Leu Thr Ala Met Thr Val Glu Ala Met Val Gly His Ala Gly Ser Phe
275 280 285
His Pro Phe Leu His Asp Val Thr Arg Pro His Pro Thr Gln Ile Glu
290 295 300
Val Ala Gly Asn Ile Arg Lys Leu Leu Glu Gly Ser Arg Phe Ala Val
305 310 315 320
His His Glu Glu Glu Val Lys Val Lys Asp Asp Glu Gly Ile Leu Arg
325 330 335
Gln Asp Arg Tyr Pro Leu Arg Thr Ser Pro Gln Trp Leu Gly Pro Leu
340 345 350
Val Ser Asp Leu Ile His Ala His Ala Val Leu Thr Ile Glu Ala Gly
355 360 365
Gln Ser Thr Thr Asp Asn Pro Leu Ile Asp Val Glu Asn Lys Thr Ser
370 375 380
His His Gly Gly Asn Phe Gln Ala Ala Ala Val Ala Asn Thr Met Glu
385 390 395 400
Lys Thr Arg Leu Gly Leu Ala Gln Ile Gly Lys Leu Asn Phe Thr Gln
405 410 415
Leu Thr Glu Met Leu Asn Ala Gly Met Asn Arg Gly Leu Pro Ser Cys
420 425 430
Leu Ala Ala Glu Asp Pro Ser Leu Ser Tyr His Cys Lys Gly Leu Asp
435 440 445
Ile Ala Ala Ala Ala Tyr Thr Ser Glu Leu Gly His Leu Ala Asn Pro
450 455 460
Val Thr Thr His Val Gln Pro Ala Glu Met Ala Asn Gln Ala Val Asn
465 470 475 480
Ser Leu Ala Leu Ile Ser Ala Arg Arg Thr Thr Glu Ser Asn Asp Val
485 490 495
Leu Ser Leu Leu Leu Ala Thr His Leu Tyr Cys Val Leu Gln Ala Ile
500 505 510
Asp Leu Arg Ala Ile Glu Phe Glu Phe Lys Lys Gln Phe Gly Pro Ala
515 520 525
Ile Val Ser Leu Ile Asp Gln His Phe Gly Ser Ala Met Thr Gly Ser
530 535 540
Asn Leu Arg Asp Glu Leu Val Glu Lys Val Asn Lys Thr Leu Ala Lys
545 550 555 560
Arg Leu Glu Gln Thr Asn Ser Tyr Asp Leu Val Pro Arg Trp His Asp
565 570 575
Ala Phe Ser Phe Ala Ala Gly Thr Val Val Glu Val Leu Ser Ser Thr
580 585 590
Ser Leu Ser Leu Ala Ala Val Asn Ala Trp Lys Val Ala Ala Ala Glu
595 600 605
Ser Ala Ile Ser Leu Thr Arg Gln Val Arg Glu Thr Phe Trp Ser Ala
610 615 620
Ala Ser Thr Ser Ser Pro Ala Leu Ser Tyr Leu Ser Pro Arg Thr Gln
625 630 635 640
Ile Leu Tyr Ala Phe Val Arg Glu Glu Leu Gly Val Lys Ala Arg Arg
645 650 655
Gly Asp Val Phe Leu Gly Lys Gln Glu Val Thr Ile Gly Ser Asn Val
660 665 670
Ser Lys Ile Tyr Glu Ala Ile Lys Ser Gly Arg Ile Asn Asn Val Leu
675 680 685
Leu Lys Met Leu Ala
690
<210> 2
<211> 2082
<212> DNA
<213>Artificial sequence
<400> 2
atggcgccgc gcccgacttc tcaaagccag gcccgcactt gcccgaccac ccaggttacc 60
caagttgata tcgttgagaa aatgctggcg gctccgactg atagcaccct ggagctggac 120
ggttatagcc tgaacctggg tgatgttgtg agcgctgcgc gtaagggtcg tccggttcgt 180
gttaaagata gcgatgaaat ccgcagcaaa atcgacaaga gcgttgaatt tctgcgcagc 240
caactgagca tgtctgttta cggtgtgacc accggctttg gcggctccgc ggacacccgc 300
accgaggacg caattagcct gcaaaaggcg ctgctggaac accagctgtg tggtgtgctg 360
ccgagcagct tcgacagctt tcgcctgggt cgtggtctgg agaacagcct gccgctggaa 420
gttgttcgcg gtgcaatgac cattcgtgtg aactctctga cccgtggcca tagcgctgtt 480
cgtctggttg ttctggaagc actgaccaac tttctgaacc acggtattac cccgattgtt 540
ccgctgcgcg gtaccatctc cgcgagcggc gatctgtctc cactgtctta cattgcagcg 600
gcgattagcg gtcacccgga tagcaaagtt cacgtggttc atgaaggcaa agagaagatc 660
ctgtacgcgc gcgaagcgat ggcgctgttt aacctggagc cggtggttct gggtccgaag 720
gagggcctgg gtctggtgaa cggtaccgca gtttccgcga gcatggcaac cctggcactg 780
cacgacgcgc acatgctgag cctgctgagc caatctctga ccgcgatgac cgtggaggcg 840
atggttggtc acgcgggcag cttccatcca ttcctgcacg atgttacccg tccgcacccg 900
acccaaatcg aggttgcggg taacattcgc aaactgctgg agggctctcg cttcgcggtt 960
caccacgagg aagaggttaa ggttaaggat gatgaaggca ttctgcgtca ggatcgttat 1020
ccgctgcgca ccagcccgca atggctgggt ccgctggtgt ccgacctgat tcacgctcat 1080
gccgttctga ccatcgaagc gggtcaaagc accaccgata acccactgat cgatgttgag 1140
aacaagacca gccatcacgg tggcaacttt caagcggcag cggttgccaa cactatggaa 1200
aagacccgtc tgggcctggc ccaaatcggt aaactgaact tcacccagct gaccgagatg 1260
ctgaacgcgg gcatgaaccg tggcctgccg agctgcctgg cggctgaaga cccatccctg 1320
agctatcatt gcaaaggtct ggacattgcg gcggctgcat ataccagcga actgggccac 1380
ctggctaacc cggttaccac ccacgttcaa ccggctgaaa tggcaaacca ggcggtgaac 1440
agcctggcgc tgattagcgc acgtcgtacc accgaatcta acgacgttct gtccctgctg 1500
ctggcaaccc acctgtactg cgtgctgcag gcgatcgacc tgcgtgcgat tgagttcgag 1560
ttcaagaaac agtttggtcc ggccattgtt agcctgatcg accaacactt tggtagcgcg 1620
atgaccggta gcaacctgcg tgatgagctg gttgaaaagg ttaacaagac tctggccaag 1680
cgtctggagc aaaccaacag ctacgatctg gttccgcgct ggcacgacgc ttttagcttc 1740
gctgcaggca ctgttgttga ggttctgtcc agcaccagcc tgagcctggc ggccgtgaac 1800
gcatggaagg ttgcggcagc cgagagcgcg atctccctga cccgccaggt tcgtgaaacc 1860
ttttggtccg ctgcaagcac ctccagcccg gcgctgtctt acctgagccc gcgcacccag 1920
atcctgtacg catttgtgcg tgaggaactg ggtgttaaag cccgccgtgg tgacgttttc 1980
ctgggtaaac aagaagttac catcggcagc aacgttagca agatttacga agccatcaag 2040
agcggccgta tcaacaacgt tctgctgaag atgctggcat aa 2082
<210> 3
<211> 5371
<212> DNA
<213>Artificial sequence
<400> 3
gccatattca acgggaaacg tcttgctcta ggccgcgatt aaattccaac atggatgctg 60
atttatatgg gtataaatgg gctcgcgata atgtcgggca atcaggtgcg acaatctatc 120
gattgtatgg gaagcccgat gcgccagagt tgtttctgaa acatggcaaa ggtagcgttg 180
ccaatgatgt tacagatgag atggtcagac taaactggct gacggaattt atgcctcttc 240
cgaccatcaa gcattttatc cgtactcctg atgatgcatg gttactcacc actgcgatcc 300
ccgggaaaac agcattccag gtattagaag aatatcctga ttcaggtgaa aatattgttg 360
atgcgctggc agtgttcctg cgccggttgc attcgattcc tgtttgtaat tgtcctttta 420
acagcgatcg cgtatttcgt ctcgctcagg cgcaatcacg aatgaataac ggtttggttg 480
atgcgagtga ttttgatgac gagcgtaatg gctggcctgt tgaacaagtc tggaaagaaa 540
tgcataaact tttgccattc tcaccggatt cagtcgtcac tcatggtgat ttctcacttg 600
ataaccttat ttttgacgag gggaaattaa taggttgtat tgatgttgga cgagtcggaa 660
tcgcagaccg ataccaggat cttgccatcc tatggaactg cctcggtgag ttttctcctt 720
cattacagaa acggcttttt caaaaatatg gtattgataa tcctgatatg aataaattgc 780
agtttcattt gatgctcgat gagtttttct aagaattaat tcatgagcgg atacatattt 840
gaatgtattt agaaaaataa acaaataggg gttccgcgca catttccccg aaaagtgcca 900
cctgaaattg taaacgttaa tattttgtta aaattcgcgt taaatttttg ttaaatcagc 960
tcatttttta accaataggc cgaaatcggc aaaatccctt ataaatcaaa agaatagacc 1020
gagatagggt tgagtgttgt tccagtttgg aacaagagtc cactattaaa gaacgtggac 1080
tccaacgtca aagggcgaaa aaccgtctat cagggcgatg gcccactacg tgaaccatca 1140
ccctaatcaa gttttttggg gtcgaggtgc cgtaaagcac taaatcggaa ccctaaaggg 1200
agcccccgat ttagagcttg acggggaaag ccggcgaacg tggcgagaaa ggaagggaag 1260
aaagcgaaag gagcgggcgc tagggcgctg gcaagtgtag cggtcacgct gcgcgtaacc 1320
accacacccg ccgcgcttaa tgcgccgcta cagggcgcgt cccattcgcc aatccggagt 1380
cgactcctcc tttcgctagc aaaaaacccc tcaagacccg tttagaggcc ccaaggggtt 1440
atgctagtta ttgctcagcg gtggcagcag ccaactcagc ttcctttact agtttgttag 1500
cagccggatc tcagtggtgg tggtggtggt gctcgagtgc ggccgcaagc ttgtagacgg 1560
agctcgaatt cggatccgcg acccatttgc tgtccaccag tcatgcttgc catatggctg 1620
ccgcgcggca ccaggccgct gctgtgatga tgatgatgat ggctgctgcc catggtatat 1680
ctccttctta aagttaaaca aaattatttc tagaggggaa ttgttatccg ctcacaattc 1740
ccctatagtg agtcgtatta atttcgcggg atcgagatct cgatcctcta cgccggacgc 1800
atcgtggccg gcatcaccgg cgcctaggtg cggttgctgg cgcctatatc gccgacatca 1860
ccgatgggga agatcgggct cgccacttcg ggctcatgag cgcttgtttc ggcgtgggta 1920
tggtggcagg ccccgtggcc gggggactgt tgggcgccat ctccttgcat gcaccattcc 1980
ttgcggcggc ggtgctcaac ggcctcaacc tactactggg ctgcttccta atgcaggagt 2040
cgcataaggg agagcgtcga gatcccggac accatcgaat ggcgcaaaac ctttcgcggt 2100
atggcatgat agcgcccgga agagagtcaa ttcagggtgg tgaatgtgaa accagtaacg 2160
ttatacgatg tcgcagagta tgccggtgtc tcttatcaga ccgtttcccg cgtggtgaac 2220
caggccagcc acgtttctgc gaaaacgcgg gaaaaagtgg aagcggcgat ggcggagctg 2280
aattacattc ccaaccgcgt ggcacaacaa ctggcgggca aacagtcgtt gctgattggc 2340
gttgccacct ccagtctggc cctgcacgcg ccgtcgcaaa ttgtcgcggc gattaaatct 2400
cgcgccgatc aactgggtgc cagcgtggtg gtgtcgatgg tagaacgaag cggcgtcgaa 2460
gcctgtaaag cggcggtgca caatcttctc gcgcaacgcg tcagtgggct gatcattaac 2520
tatccgctgg atgaccagga tgccattgct gtggaagctg cctgcactaa tgttccggcg 2580
ttatttcttg atgtctctga ccagacaccc atcaacagta ttattttctc ccatgaagac 2640
ggtacgcgac tgggcgtgga gcatctggtc gcattgggtc accagcaaat cgcgctgtta 2700
gcgggcccat taagttctgt ctcggcgcgt ctgcgtctgg ctggctggca taaatatctc 2760
actcgcaatc aaattcagcc gatagcggaa cgggaaggcg actggagtgc catgtccggt 2820
tttcaacaaa ccatgcaaat gctgaatgag ggcatcgttc ccactgcgat gctggttgcc 2880
aacgatcaga tggcgctggg cgcaatgcgc gccattaccg agtccgggct gcgcgttggt 2940
gcggatatct cggtagtggg atacgacgat accgaagaca gctcatgtta tatcccgccg 3000
ttaaccacca tcaaacagga ttttcgcctg ctggggcaaa ccagcgtgga ccgcttgctg 3060
caactctctc agggccaggc ggtgaagggc aatcagctgt tgcccgtctc actggtgaaa 3120
agaaaaacca ccctggcgcc caatacgcaa accgcctctc cccgcgcgtt ggccgattca 3180
ttaatgcagc tggcacgaca ggtttcccga ctggaaagcg ggcagtgagc gcaacgcaat 3240
taatgtaagt tagctcactc attaggcacc gggatctcga ccgatgccct tgagagcctt 3300
caacccagtc agctccttcc ggtgggcgcg gggcatgact atcgtcgccg cacttatgac 3360
tgtcttcttt atcatgcaac tcgtaggaca ggtgccggca gcgctctggg tcattttcgg 3420
cgaggaccgc tttcgctgga gcgcgacgat gatcggcctg tcgcttgcgg tattcggaat 3480
cttgcacgcc ctcgctcaag ccttcgtcac tggtcccgcc accaaacgtt tcggcgagaa 3540
gcaggccatt atcgccggca tggcggcccc acgggtgcgc atgatcgtgc tcctgtcgtt 3600
gaggacccgg ctaggctggc ggggttgcct tactggttag cagaatgaat caccgatacg 3660
cgagcgaacg tgaagcgact gctgctgcaa aacgtctgcg acctgagcaa caacatgaat 3720
ggtcttcggt ttccgtgttt cgtaaagtct ggaaacgcgg aagtcagcgc cctgcaccat 3780
tatgttccgg atctgcatcg caggatgctg ctggctaccc tgtggaacac ctacatctgt 3840
attaacgaag cgctggcatt gaccctgagt gatttttctc tggtcccgcc gcatccatac 3900
cgccagttgt ttaccctcac aacgttccag taaccgggca tgttcatcat cagtaacccg 3960
tatcgtgagc atcctctctc gtttcatcgg tatcattacc cccatgaaca gaaatccccc 4020
ttacacggag gcatcagtga ccaaacagga aaaaaccgcc cttaacatgg cccgctttat 4080
cagaagccag acattaacgc ttctggagaa actcaacgag ctggacgcgg atgaacaggc 4140
agacatctgt gaatcgcttc acgaccacgc tgatgagctt taccgcagct gcctcgcgcg 4200
tttcggtgat gacggtgaaa acctctgaca catgcagctc ccggagacgg tcacagcttg 4260
tctgtaagcg gatgccggga gcagacaagc ccgtcagggc gcgtcagcgg gtgttggcgg 4320
gtgtcggggc gcagccatga cccagtcacg tagcgatagc ggagtgtata ctggcttaac 4380
tatgcggcat cagagcagat tgtactgaga gtgcaccata tatgcggtgt gaaataccgc 4440
acagatgcgt aaggagaaaa taccgcatca ggcgctcttc cgcttcctcg ctcactgact 4500
cgctgcgctc ggtcgttcgg ctgcggcgag cggtatcagc tcactcaaag gcggtaatac 4560
ggttatccac agaatcaggg gataacgcag gaaagaacat gtgagcaaaa ggccagcaaa 4620
aggccaggaa ccgtaaaaag gccgcgttgc tggcgttttt ccataggctc cgcccccctg 4680
acgagcatca caaaaatcga cgctcaagtc agaggtggcg aaacccgaca ggactataaa 4740
gataccaggc gtttccccct ggaagctccc tcgtgcgctc tcctgttccg accctgccgc 4800
ttaccggata cctgtccgcc tttctccctt cgggaagcgt ggcgctttct catagctcac 4860
gctgtaggta tctcagttcg gtgtaggtcg ttcgctccaa gctgggctgt gtgcacgaac 4920
cccccgttca gcccgaccgc tgcgccttat ccggtaacta tcgtcttgag tccaacccgg 4980
taagacacga cttatcgcca ctggcagcag ccactggtaa caggattagc agagcgaggt 5040
atgtaggcgg tgctacagag ttcttgaagt ggtggcctaa ctacggctac actagaagga 5100
cagtatttgg tatctgcgct ctgctgaagc cagttacctt cggaaaaaga gttggtagct 5160
cttgatccgg caaacaaacc accgctggta gcggtggttt ttttgtttgc aagcagcaga 5220
ttacgcgcag aaaaaaagga tctcaagaag atcctttgat cttttctacg gggtctgacg 5280
ctcagtggaa cgaaaactca cgttaaggga ttttggtcat gaacaataaa actgtctgct 5340
tacataaaca gtaatacaag gggtgttatg a 5371
<210> 4
<211> 20
<212> DNA
<213>Artificial sequence
<400> 4
aagaaagcga aaggagcggg 20
<210> 5
<211> 20
<212> DNA
<213>Artificial sequence
<400> 5
ccatacccac gccgaaacaa 20
Claims (10)
1. a kind of caffeinic efficient resting cell method, it is characterised in that to express tyrosine amino lyase RgTAL's
Recombination bacillus coli, whole-cell catalytic levodopa Synthesis caffeic acid.
2. a kind of caffeinic bioconversion method according to claim 1, it is characterised in that described tyrosine amino
The amino acid sequence of lyase RgTAL is as shown in SEQ ID NO.1.
3. a kind of caffeinic biological synthesis method according to claim 1 and 2, it is characterised in that described large intestine bar
Bacterium is e. coli bl21 (DE3).
4. according to any described a kind of caffeinic biological synthesis method of claims 1 to 3, it is characterised in that table used
It is pET-28a (PB) up to carrier.
5. a kind of caffeinic biological synthesis method according to claim 4, it is characterised in that encoding tyrosine amino splits
The gene RgTAL of synthase is subcloned to expression vector pET-28a (PB) by restriction enzyme site Bam HI/Hind III.
6. according to any described a kind of caffeinic biological synthesis method of Claims 1 to 5, it is characterised in that full cell turns
The reaction medium of change system is the phosphate buffer of 10-200mM, and the concentration of recombination bacillus coli is in resting cell system
OD600=20 ± 1, substrate concentration range is 0.01-10g/L, and the pH scopes of described resting cell system are 6.0-9.0, instead
It is 25-42 DEG C to answer temperature range.
7. a kind of caffeinic biological synthesis method according to claim 6, it is characterised in that described reaction medium is
The phosphate buffer of 10-200mM.
8. a kind of caffeinic biological synthesis method according to claim 6, it is characterised in that the reaction of resting cell
Medium is the phosphate buffer of 50mM, and the concentration of recombination bacillus coli is OD in resting cell system600=20 ± 1, substrate
Concentration is 1g/L, and the pH scopes of described reaction system are 7.5, and range of reaction temperature is 37 DEG C.
9. a kind of recombination bacillus coli, it is characterised in that expression tyrosine amino lyase RgTAL.
10. a kind of recombination bacillus coli according to claim 9, it is characterised in that described tyrosine amino lyase
As shown in SEQ ID NO.1, e. coli bl21 (DE3) is host to the amino acid sequence of RgTAL, and expression vector is pET-28a
(PB)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611158372.2A CN106755135B (en) | 2016-12-15 | 2016-12-15 | Method for whole-cell transformation synthesis of caffeic acid by taking levodopa as substrate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611158372.2A CN106755135B (en) | 2016-12-15 | 2016-12-15 | Method for whole-cell transformation synthesis of caffeic acid by taking levodopa as substrate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106755135A true CN106755135A (en) | 2017-05-31 |
CN106755135B CN106755135B (en) | 2020-04-21 |
Family
ID=58888311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611158372.2A Active CN106755135B (en) | 2016-12-15 | 2016-12-15 | Method for whole-cell transformation synthesis of caffeic acid by taking levodopa as substrate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106755135B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108949652A (en) * | 2018-04-19 | 2018-12-07 | 江南大学 | A kind of engineering bacteria and its caffeinic application of production |
CN110241146A (en) * | 2019-06-27 | 2019-09-17 | 杭州唯铂莱生物科技有限公司 | A kind of 3,4- dihydroxycinnamic acid that combination enzyme process prepares the method for 3,4- dihydroxycinnamic acid and produced by this method |
CN117866867A (en) * | 2024-03-12 | 2024-04-12 | 天津科技大学 | Caffeic acid production strain, construction method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008069958A2 (en) * | 2006-12-01 | 2008-06-12 | The Salk Institute For Biological Studies | Substrate switched ammonia lyases and mutases |
US20120034661A1 (en) * | 2010-05-07 | 2012-02-09 | The Research Foundation Of State University Of New York | Strains for the production of flavonoids from glucose |
CN105283547A (en) * | 2012-12-27 | 2016-01-27 | 罗地亚经营管理公司 | Recombinant host cell for biosynthetic production |
-
2016
- 2016-12-15 CN CN201611158372.2A patent/CN106755135B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008069958A2 (en) * | 2006-12-01 | 2008-06-12 | The Salk Institute For Biological Studies | Substrate switched ammonia lyases and mutases |
US20120034661A1 (en) * | 2010-05-07 | 2012-02-09 | The Research Foundation Of State University Of New York | Strains for the production of flavonoids from glucose |
CN105283547A (en) * | 2012-12-27 | 2016-01-27 | 罗地亚经营管理公司 | Recombinant host cell for biosynthetic production |
Non-Patent Citations (4)
Title |
---|
JUNJUN WU 等: ""Modular Optimization of Heterologous Pathways for De Novo Synthesis of (2S)-Naringenin in Escherichia coli"", 《PLOS ONE》 * |
WU,J. 等: ""Rhodotorula glutinis tyrosine ammonia lyase (TAL) mRNA, complete cds"", 《GENBANK DATABASE》 * |
YUHENG LIN 等: ""Biosynthesis of caffeic acid in Escherichia coli using its endogenous hydroxylase complex"", 《MICROBIAL CELL FACTORIES》 * |
梁景龙 等: ""粘红酵母酪氨酸解氨酶基因的克隆表达与酶学性质"", 《中国食品学报》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108949652A (en) * | 2018-04-19 | 2018-12-07 | 江南大学 | A kind of engineering bacteria and its caffeinic application of production |
CN110241146A (en) * | 2019-06-27 | 2019-09-17 | 杭州唯铂莱生物科技有限公司 | A kind of 3,4- dihydroxycinnamic acid that combination enzyme process prepares the method for 3,4- dihydroxycinnamic acid and produced by this method |
CN117866867A (en) * | 2024-03-12 | 2024-04-12 | 天津科技大学 | Caffeic acid production strain, construction method and application thereof |
CN117866867B (en) * | 2024-03-12 | 2024-05-28 | 天津科技大学 | Caffeic acid production strain, construction method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN106755135B (en) | 2020-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106591383B (en) | Method for efficiently synthesizing caffeic acid by using catechol as substrate | |
CN106701843A (en) | High efficiency biosynthesis method of caffeic acid with catechol as substrate | |
KR102278000B1 (en) | The method of producing L-tryptophan using enhancing the activity of prephenate dehydratase | |
CN107164255B (en) | Method for producing glucaric acid by constructing recombinant saccharomyces cerevisiae fermentation | |
CN106755135A (en) | It is a kind of to synthesize caffeinic method by substrate resting cell of levodopa | |
CN106591390B (en) | One kind is from main removing H2O2The enzyme grade method that is unified into rosin element | |
CN115038714A (en) | Mutant of inner membrane protein and method for producing target product by using the same | |
KR102257842B1 (en) | Novel D-alanine-D-alanine ligase A variant and a method for producing L-glutamic acid using the same | |
CN108913718A (en) | A kind of preparation method and application of the CAR-T cell of targeting EGFR v III | |
CN106497990B (en) | It is a kind of to convert caffeinic high-performance bio synthetic method for low value compound | |
KR20150131880A (en) | A microorganism having enhanced productivity of succinate and a method for producing succinate using the same | |
CN108753745B (en) | Ethanol dehydrogenase mutant and encoding gene and application thereof | |
CN109022363A (en) | A kind of CD-133-CAR-T system constituting method based on PiggyBac carrier | |
CN113406331A (en) | Fungal immunomodulatory protein cell positioning method based on green fluorescent protein | |
CN106978432A (en) | Knock out carrier construction method and the application of chlamydomonas endogenous gene and expression alien gene | |
CN115135759A (en) | Novel glucosamine-6-phosphate deaminase variant and method for producing L-glutamic acid using same | |
RU2804941C1 (en) | Variant of inner membrane protein and method for obtaining target product using it | |
RU2814875C1 (en) | Method of producing l-tryptophan by enhancing prephenate dehydratase activity | |
RU2793443C1 (en) | New variant of 5.10-methylenetetrahydrofolate reductase and a method for obtaining l-valine with its use | |
RU2793468C1 (en) | New variant of tetrahydrodipicolinate-n-succinyltransferase and a method for obtaining l-valine with its use | |
RU2793442C1 (en) | New option of asparagine synthase and a method for obtaining l-valine using it | |
RU2817194C1 (en) | Recombinant microorganism for producing l-glutamic acid and method of producing l-glutamic acid using same | |
RU2795789C1 (en) | New variant of the auxiliary urease protein and a method for obtaining l-valine with its use | |
KR102257841B1 (en) | Novel phytoene synthase variant and a method for producing XMP or GMP using the same | |
CN113950525B (en) | Novel ribonuclease P variants and method for producing L-glutamic acid using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |